Valsartan MDL Expanded To Include 2 Related Drugs Containing Carcinogen NDMA

Mealey's (January 8, 2020, 9:33 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 18 expanded the valsartan multidistrict litigation to include losartan and irbesartan, all high blood pressure drugs allegedly containing N-nitrosodimethylamine...
To view the full article, register now.